Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 2Completed 2Active not recruiting 2Recruiting 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 5Other hematologic neoplasm 3Classical hematology 2Other neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 306Lymphoma, Non-Hodgkin 227Lymphoma, Large B-Cell, Diffuse 220Lymphoma, Follicular 201Leukemia, Lymphocytic, Chronic, B-Cell 168Lymphoma, B-Cell 147Recurrence 124Burkitt Lymphoma 117Lymphoma, Mantle-Cell 112Leukemia, Myeloid, Acute 106Leukemia 103Hodgkin Disease 102Multiple Myeloma 95Lymphoma, B-Cell, Marginal Zone 87Neoplasms 80Myelodysplastic Syndromes 69Lymphoma, T-Cell, Peripheral 62Hematologic Neoplasms 61Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58Lymphoma, T-Cell 52Lymphoma, T-Cell, Cutaneous 44Waldenstrom Macroglobulinemia 41Leukemia, Biphenotypic, Acute 35Mycosis Fungoides 31Lymphoproliferative Disorders 30Leukemia, B-Cell 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Breast Neoplasms 28Myeloproliferative Disorders 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Bone Marrow Diseases × Lymphoid × Clear all
NCT06034275 2024-11-15

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Vincerx Pharma, Inc.

Phase 1 Recruiting
36 enrolled
LymphoidOther hematologic neoplasm

Bone Marrow Diseases, Burkitt Lymphoma, Hematologic Diseases, Leukemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡